← Insider buys
SAGE

Sage Therapeutics, Inc.

Director Steven M Paul sold $322K of Sage Therapeutics, Inc.

Sold$322,000
$161.00Price
2,000Shares

What SAGE did after the filing

Prices for SAGE after this filing aren't in yet.

Traded Mon, Feb 25. Filed Wed, Feb 27, 5:48 PM ET, after the close. Not investment advice.